This study is looking at the experiences of people with neuroendocrine tumors (NETs) who consider or join clinical trials. It's an observational study, meaning researchers will gather information from 500 participants to understand what helps or hinders them from joining or completing a trial. The goal is to identify factors that might make it easier for future NET patients to participate in research. You can join if you are at least 18 years old, have a neuroendocrine tumor diagnosis, and can understand and sign a consent form. The study will measure how many patients decide to join research within 3 months and how many stay in a trial until it's finished, looking at these numbers over 12 months.

Study design

This is an observational study aiming to enroll 500 participants. It is not testing a specific treatment, but rather collecting information about patient experiences.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

The study will track patient participation for up to 12 months, with initial measurements at 3 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.